Literature DB >> 6806378

Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine.

P T Le, M T Muller, R F Mortensen.   

Abstract

The acute phase reactant of mice, serum amyloid P-component (SAP), was purified and separated from C-reactive protein (CRP). The purified SAP is composed of identical M, 31 Kd polypeptide subunits, determined by SDS-PAGE. SAP levels increased five-fold by 24 hr after challenge with lipopolysaccharide (LPS) or thioglycollate. This response closely correlated with blood monocytosis and required new macromolecule (protein + RNA) synthesis and secretion by the liver. The induction of the SAP response was adoptively transferred by a serum factor produced in optimal concentrations only 90 min after an inflammatory stimulus, which preceded a detectable increase in SAP. A potent SAP inducer was identified in culture supernatants of LPS-activated macrophages. The rapid induction of SAP synthesis in LPS-unresponsive C3H/HeJ mice was dependent on the amount of lymphocyte-activating factor, LAF(IL 1), present in the macrophage culture supernatants. Partially purified human IL 1 also induced a rapid increase in SAP. Thus the induction of SAP in mice appears to be mediated by a product of macrophages, a cell population that is also expanded as part of the systemic inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

Authors:  B Weinhold; A Bader; V Poli; U Rüther
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.

Authors:  Jenny E Kanter; Baohai Shao; Farah Kramer; Shelley Barnhart; Masami Shimizu-Albergine; Tomas Vaisar; Mark J Graham; Rosanne M Crooke; Clarence R Manuel; Rebecca A Haeusler; Daniel Mar; Karol Bomsztyk; John E Hokanson; Gregory L Kinney; Janet K Snell-Bergeon; Jay W Heinecke; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2019-07-11       Impact factor: 14.808

3.  Serum amyloid P-component-induced enhancement of macrophage listericidal activity.

Authors:  P P Singh; F Gervais; E Skamene; R F Mortensen
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.

Authors:  A J Szalai; D E Briles; J E Volanakis
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Sequential measurement of the murine acute-phase protein serum amyloid P component (SAP) as an indicator of graft-versus-host disease following allogeneic bone marrow transplantation in mice.

Authors:  K F Bayston; R Huby; J Cohen
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Mouse serum amyloid P-component (SAP) levels controlled by a locus on chromosome 1.

Authors:  R F Mortensen; P T Le; B A Taylor
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP).

Authors:  B F Lin; N O Ku; K Zahedi; A S Whitehead; R F Mortensen
Journal:  Inflammation       Date:  1990-06       Impact factor: 4.092

8.  Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells.

Authors:  H Baumann; R E Hill; D N Sauder; G P Jahreis
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

9.  Observations on the delay in onset of the acute phase protein response.

Authors:  M A Myers; A Fleck
Journal:  Br J Exp Pathol       Date:  1988-04

10.  Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.

Authors:  C Rordorf-Adam; D Serban; A Pataki; M Grüninger
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.